Koyfin Home > Directory > Health Care > Aimmune Therap > Price / Book

Aimmune Therap Price / Book Chart (AIMT)

Aimmune Therap annual/quarterly Price / Book from 2015 to 2020. Price-to-book value (P/B) is the ratio of market value of a company's shares (share price) over its book value of equity. The book value of equity, in turn, is the value of a company's assets expressed on the balance sheet.
  • Aimmune Therap Price / Book for the quarter ending September 09, 2020 was 12.49 a 0.04% increase of 0.01 year over year
  • Aimmune Therap Price / Book for the last 12 months ending September 09, 2020 was 12.49 a 0.04% increase of 0.01 year over year
  • Aimmune Therap Annual Price / Book for 2020 was 12.49 a 0.06% increase of 0.01 from 2019
  • Aimmune Therap Annual Price / Book for 2020 was 12.48 a 0.03% increase of 0.00 from 2019
  • Aimmune Therap Annual Price / Book for 2020 was 12.48 a -0.04% decrease of -0.01 from 2019
Other Valuation Metrics:
  • Aimmune Therap Market Cap for the quarter ending March 03, 2018 was $1,841m a 43.79% increase of 806m year over year
  • Aimmune Therap Enterprise Value for the quarter ending March 03, 2018 was $1,659m a 52.45% increase of 870m year over year
View Chart On Koyfin

Quarterly AIMT Price / Book Data

09/202012.49
09/202012.48
09/202012.48
09/202012.48
09/202012.48
09/202012.48
09/202012.44
09/202012.44
09/202012.44
09/202012.43

Annual AIMT Price / Book Data

202012.49
202012.48
202012.48
202012.48
202012.48
202012.48
202012.44
202012.44
202012.44
202012.43